MedTrace Logo

The Effects of Soy Protein and Isoflavones on Glycemic Control, Insulin Sensitivity and Cardiovascular Risk Factors

NCT00856882 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL

Last updated 2009-03-06

No results posted yet for this study

Summary

The investigators propose to perform a double-blind, randomized placebo-controlled trial to examine the hypothesis that soy protein with isoflavones could improve glycemic control, insulin sensitivity and decrease cardiovascular risk factors in postmenopausal women with prediabetes.

Conditions

Interventions

DIETARY_SUPPLEMENT

soy protein

DIETARY_SUPPLEMENT

isoflavones

DIETARY_SUPPLEMENT

milk protein

Sponsors & Collaborators

  • Chinese University of Hong Kong

    lead OTHER

Eligibility

Min Age
46 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-10-31
Primary Completion
2008-04-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00856882 on ClinicalTrials.gov